Manulife (Manufacturers Life Insurance)
IONS icon

Manulife (Manufacturers Life Insurance)’s Ionis Pharmaceuticals IONS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2M Sell
149,538
-3,703
-2% -$292K 0.01% 807
2025
Q4 		$12.1M Buy
153,241
+55,218
+56% +$4.16M 0.01% 792
2025
Q3 		$6.41M Buy
98,023
+14,637
+18% +$715K 0.01% 1069
2025
Q2 		$3.29M Sell
83,386
-54
-0.1% -$1.77K ﹤0.01% 1327
2025
Q1 		$2.52M Sell
83,440
-202,839
-71% -$6.64M ﹤0.01% 1399
2024
Q4 		$10M Sell
286,279
-22,668
-7% -$847K 0.01% 888
2024
Q3 		$12.4M Buy
308,947
+34,097
+12% +$1.59M 0.01% 792
2024
Q2 		$13.1M Buy
274,850
+29,783
+12% +$1.22M 0.01% 734
2024
Q1 		$10.6M Sell
245,067
-15,635
-6% -$745K 0.01% 829
2023
Q4 		$13.2M Buy
260,702
+31,025
+14% +$1.49M 0.01% 745
2023
Q3 		$10.4M Sell
229,677
-33,882
-13% -$1.4M 0.01% 792
2023
Q2 		$10.8M Buy
263,559
+190,947
+263% +$7.34M 0.01% 767
2023
Q1 		$2.6M Sell
72,612
-9,911
-12% -$372K ﹤0.01% 1334
2022
Q4 		$3.08M Sell
82,523
-6,573
-7% -$276K ﹤0.01% 1271
2022
Q3 		$3.94M Sell
89,096
-4,118
-4% -$174K ﹤0.01% 1148
2022
Q2 		$3.5M Buy
93,214
+17,916
+24% +$676K ﹤0.01% 1259
2022
Q1 		$2.69M Buy
+75,298
New +$2.46M ﹤0.01% 1433
2020
Q1 		– Sell
-3,543
Closed -$214K – 2863
2019
Q4 		$214K Sell
3,543
-108
-3% -$6.43K ﹤0.01% 2553
2019
Q3 		$216K Buy
3,651
+172
+5% +$11.2K ﹤0.01% 2537
2019
Q2 		$224K Buy
3,479
+392
+13% +$27.7K ﹤0.01% 2574
2019
Q1 		$251K Buy
+3,087
New +$199K ﹤0.01% 2312
2018
Q3 		– Sell
-3,876
Closed -$162K – 3407
2018
Q2 		$162K Sell
3,876
-58
-1% -$2.57K ﹤0.01% 3267
2018
Q1 		$174K Buy
3,934
+11
+0.3% +$559 ﹤0.01% 3121
2017
Q4 		$197K Sell
3,923
-104
-3% -$5.7K ﹤0.01% 3011
2017
Q3 		$205K Buy
4,027
+283
+8% +$14.8K ﹤0.01% 2957
2017
Q2 		$190K Buy
3,744
+311
+9% +$14.5K ﹤0.01% 3059
2017
Q1 		$138K Hold
3,433
– – ﹤0.01% 3039
2016
Q4 		$164K Hold
3,433
– – ﹤0.01% 2940
2016
Q3 		$126K Sell
3,433
-862
-20% -$27K ﹤0.01% 3092
2016
Q2 		$101K Buy
4,295
+83
+2% +$2.68K ﹤0.01% 3206
2016
Q1 		$163K Buy
4,212
+110
+3% +$4.47K ﹤0.01% 2745
2015
Q4 		$254 Hold
4,102
– – ﹤0.01% 2473
2015
Q3 		$166 Sell
4,102
-55
-1% -$2.85K ﹤0.01% 2794
2015
Q2 		$239 Sell
4,157
-156,284
-97% -$9.94M ﹤0.01% 2716
2015
Q1 		$10.2K Sell
160,441
-5,032
-3% -$341K 0.01% 687
2014
Q4 		$10.2K Sell
165,473
-24,825
-13% -$1.23M 0.01% 630
2014
Q3 		$7.39K Sell
190,298
-8,414
-4% -$298K 0.01% 779
2014
Q2 		$6.85M Buy
198,712
+50,533
+34% +$1.59M 0.01% 830
2014
Q1 		$6.4K Buy
148,179
+63,124
+74% +$3.06M 0.01% 899
2013
Q4 		$3.39K Buy
85,055
+403
+0.5% +$14.4K 0.01% 1177
2013
Q3 		$3.18K Sell
84,652
-1,315
-2% -$39.3K 0.01% 1146
2013
Q2 		$2.31M Buy
+85,967
New +$1.83M ﹤0.01% 1196

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IONS Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Ionis Pharmaceuticals (IONS) stake by 2.4% in Q1 2026, selling an estimated $292K and leaving 149,538 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #807.

Manulife (Manufacturers Life Insurance) first reported a position in IONS in Q2 2013 and has held it in 42 quarters since. The position peaked at $13.2M in Q4 2023. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 149,538 shares of Ionis Pharmaceuticals worth $11.2M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 3,703 Ionis Pharmaceuticals shares in Q1 2026, an estimated $292K.
  • Ionis Pharmaceuticals made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #807 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Ionis Pharmaceuticals position peaked at $13.2M in Q4 2023.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.